We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
-$238M
Cap. Flow
-$147M
Cap. Flow %
-12.32%
Top 10 Hldgs %
60.4%
Holding
78
New
16
Increased
22
Reduced
29
Closed
7

Top Buys

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$23.6M
2
HCA icon
HCA Healthcare
HCA
+$14.7M
3
TECH icon
Bio-Techne
TECH
+$12.4M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$11.9M
5
KRYS icon
Krystal Biotech
KRYS
+$10.9M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$42.8M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$36.3M
3
GSK icon
GSK
GSK
+$30.5M
4
NTRA icon
Natera
NTRA
+$20.7M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 77.99%
2 Miscellaneous 20.84%
3 Communication Services 0.66%
4 Financials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNC icon
26
Centene
CNC
$32B
$10.3M 0.86%
152,733
-135,693
-47% -$9.05M
IONS icon
27
Ionis Pharmaceuticals
IONS
$10.1B
$9.91M 0.83%
241,572
-61,797
-20% -$2.37M
PCVX icon
28
Vaxcyte
PCVX
$8.9B
$9.77M 0.82%
195,691
-103,359
-35% -$4.9M
TARO
29
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$9.49M 0.79%
250,286
+5,019
+2% +$158K
RGEN icon
30
Repligen
RGEN
$9.95B
$9.35M 0.78%
66,067
+60,411
+1,068% +$9.69M
IFRX icon
31
InflaRx
IFRX
$329M
$8.54M 0.71%
+1,915,113
New +$8.57M
NAMS icon
32
NewAmsterdam Pharma
NAMS
$3.1B
$8.23M 0.69%
692,369
+646,513
+1,410% +$8.58M
MODN
33
DELISTED
MODEL N, INC.
MODN
$7.89M 0.66%
223,168
-18,702
-8% -$601K
XBI icon
34
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$7.49M 0.63%
90,000
+10,000
+13% +$836K
LQDA icon
35
Liquidia Corp
LQDA
$6.06B
$7.26M 0.61%
925,444
+201,038
+28% +$1.56M
XENE icon
36
Xenon Pharmaceuticals
XENE
$5.81B
$6.6M 0.55%
171,378
-31,894
-16% -$1.27M
MOH icon
37
Molina Healthcare
MOH
$10.4B
$6.4M 0.54%
+21,254
New +$6.11M
PBYI icon
38
Puma Biotechnology
PBYI
$468M
$5.85M 0.49%
1,658,195
-279,893
-14% -$873K
SWAV
39
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$5.75M 0.48%
20,138
-27,439
-58% -$7.62M
HUM icon
40
Humana
HUM
$46.3B
$5.34M 0.45%
11,927
-10,835
-48% -$5.45M
PNTG icon
41
Pennant Group
PNTG
$1.3B
$5.3M 0.44%
431,622
+9,648
+2% +$123K
APLS
42
DELISTED
Apellis Pharmaceuticals
APLS
$5.14M 0.43%
+56,449
New +$4.87M
KURA icon
43
Kura Oncology
KURA
$1.13B
$4.77M 0.4%
+450,622
New +$5.33M
IQV icon
44
IQVIA
IQV
$43.1B
$4.21M 0.35%
18,748
+4,332
+30% +$870K
EHTH icon
45
eHealth
EHTH
$38.4M
$4.04M 0.34%
503,079
-731,204
-59% -$5.85M
MEDP icon
46
Medpace
MEDP
$16.8B
$3.74M 0.31%
15,564
+3,896
+33% +$809K
CVAC
47
DELISTED
CureVac
CVAC
$3.72M 0.31%
+357,342
New +$3.2M
STRO icon
48
Sutro Biopharma
STRO
$339M
$3.48M 0.29%
+74,791
New +$3.72M
MRUS
49
DELISTED
Merus
MRUS
$3.46M 0.29%
131,226
+2,170
+2% +$47.5K
A icon
50
Agilent Technologies
A
$43.4B
$3.43M 0.29%
28,460
+15,350
+117% +$1.96M
1
2
3 4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Eversept Partners held 78 positions worth $1.2B, down 17% from $1.43B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Eversept Partners withdrew a net $147M in Q2 2023, closing 7 positions and reducing 29 holdings. Its most notable exit was Biogen, an estimated $42.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 76% a quarter earlier, followed by Miscellaneous and Communication Services.

Against the trend, Eversept Partners opened a new position in Inspire Medical Systems worth $26.8M.

  • Eversept Partners's largest Q2 2023 buy was Inspire Medical Systems: 82,445 shares worth $26.8M.
  • Eversept Partners added most to HCA Healthcare in Q2 2023, an estimated $14.7M increase.
  • Eversept Partners's biggest Q2 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $36.3M.
  • Eversept Partners fully exited Biogen in Q2 2023, selling an estimated $42.8M.
  • Eversept Partners's ten largest holdings make up 60% of its $1.2B portfolio in Q2 2023.
  • Eversept Partners opened 16 new positions and closed 7 in Q2 2023.
  • Eversept Partners's portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Eversept Partners's 13F filing for Q2 2023, filed 14 Aug 2023.